Braveheart Bio, Inc. (BRVE) is listed on NASDAQ in the Manufacturing sector. This page tracks real-time BRVE price, technical indicators including RSI, MACD, and the 52-week range, plus fundamentals, earnings history, and recent insider trading activity.
Technical Analysis
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Ah Bio Fund Iv, L.p. | Insider | Buy | 1,100,000 | $18.00 | $19.8M | 2026 Aug 7 |
| Chimovits Erez | Director | Buy | 1,940,000 | $18.00 | $34.9M | 2026 Aug 7 |
| Orbimed Advisors LLC | Director | Buy | 1,940,000 | $18.00 | $34.9M | 2026 Aug 7 |
| Forbion Growth Opportunities Fund III Cooperatief U.a. | Insider | Buy | 3,600,000 | $18.00 | $64.8M | 2026 Aug 7 |
| Rickey James Paul | Chief Financial Officer | Buy | 27,777 | $18.00 | $499,986 | 2026 Aug 7 |
| Viehbacher Christopher | Director | Buy | 83,333 | $18.00 | $1.5M | 2026 Aug 7 |
| Malek David I | Director | Buy | 4,166 | $18.00 | $74,988 | 2026 Aug 7 |
| Anderson Michele A. | Chief Development Officer | Buy | 1,111 | $18.00 | $19,998 | 2026 Aug 7 |
| Murdoch Travis | CEO and President | Buy | 83,333 | $18.00 | $1.5M | 2026 Aug 7 |
| Lubner David Charles | Director | Buy | 55,555 | $18.00 | $999,990 | 2026 Aug 7 |
Take BRVE further
- Browse Pharmaceutical Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put BRVE in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Braveheart Bio, Inc. next reports.
Set alerts on BRVE
Get notified when Braveheart Bio, Inc. hits your price targets or technical conditions are met.
Get Started Free